PTPN13/PTPL1: An Important Regulator of Tumor Aggressiveness

E-ISSN： 1875-5992|11|1|78-88

ISSN： 1871-5206

Source： Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol.11, Iss.1, 2011-01, pp. : 78-88

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Promoter hypermethylation of PTPL1, PTPN6, DAPK, p16 and 5-azacitidine inhibits growth in DLBCL

Oncology Reports, Vol. 35, Iss. 1, 2016-01 ,pp. : 139-146

Spandidos Publications

Access to resources Recommend Favorite

SGK1, a potential regulator of c-fms related breast cancer aggressiveness

By Tangir Jacob Bonafé Nathalie Gilmore-Hebert Maureen Henegariu Octavian Chambers Setsuko

Clinical and Experimental Metastasis, Vol. 21, Iss. 6, 2004-10 ,pp. : 477-483

Springer Publishing Company

Access to resources Recommend Favorite

Podocalyxin-like 1 is associated with tumor aggressiveness and metastatic gene expression in human oral squamous cell carcinoma

By Lin Cheng-Wei Sun Min-Siou Wu Han-Chung

International Journal of Oncology, Vol. 45, Iss. 2, 2014-08 ,pp. : 710-718

Spandidos Publications

Access to resources Recommend Favorite

Expression of MUC1 recognized by monoclonal antibody MY.1E12 is a useful biomarker for tumor aggressiveness of advanced colon carcinoma

By Suzuki Hideo Shoda Junichi Kawamoto Toru Shinozaki Eiji Miyahara Naoki Hotta Souichi Iizuka Yasushi Nakahara Akira Tanaka Naomi Yanaka Akinori Irimura Tatsuro

Clinical and Experimental Metastasis, Vol. 21, Iss. 4, 2004-10 ,pp. : 321-329

Springer Publishing Company

Access to resources Recommend Favorite

A role for LRIG1 in the regulation of malignant glioma aggressiveness

International Journal of Oncology, Vol. 42, Iss. 3, 2013-01 ,pp. : 1081-1087

Spandidos Publications

Access to resources Recommend Favorite